» Articles » PMID: 35925520

Evolution and Molecular Interactions of Major Histocompatibility Complex (MHC)-G, -E and -F Genes

Abstract

Classical HLA (Human Leukocyte Antigen) is the Major Histocompatibility Complex (MHC) in man. HLA genes and disease association has been studied at least since 1967 and no firm pathogenic mechanisms have been established yet. HLA-G immune modulation gene (and also -E and -F) are starting the same arduous way: statistics and allele association are the trending subjects with the same few results obtained by HLA classical genes, i.e., no pathogenesis may be discovered after many years of a great amount of researchers' effort. Thus, we believe that it is necessary to follow different research methodologies: (1) to approach this problem, based on how evolution has worked maintaining together a cluster of immune-related genes (the MHC) in a relatively short chromosome area since amniotes to human at least, i.e., immune regulatory genes (MHC-G, -E and -F), adaptive immune classical class I and II genes, non-adaptive immune genes like (C2, C4 and Bf) (2); in addition to using new in vitro models which explain pathogenetics of HLA and disease associations. In fact, this evolution may be quite reliably studied during about 40 million years by analyzing the evolution of MHC-G, -E, -F, and their receptors (KIR-killer-cell immunoglobulin-like receptor, NKG2-natural killer group 2-, or TCR-T-cell receptor-among others) in the primate evolutionary lineage, where orthology of these molecules is apparently established, although cladistic studies show that MHC-G and MHC-B genes are the ancestral class I genes, and that New World apes MHC-G is paralogous and not orthologous to all other apes and man MHC-G genes. In the present review, we outline past and possible future research topics: co-evolution of adaptive MHC classical (class I and II), non-adaptive (i.e., complement) and modulation (i.e., non-classical class I) immune genes may imply that the study of full or part of MHC haplotypes involving several loci/alleles instead of single alleles is important for uncovering HLA and disease pathogenesis. It would mainly apply to starting research on HLA-G extended haplotypes and disease association and not only using single HLA-G genetic markers.

Citing Articles

Two different complement Factor B (Bf) alleles of the orangutan major histocompatibility complex (MHC) are also conserved in chimpanzee and humans showing importance in primate immunity.

Arnaiz-Villena A, Juarez I, Vaquero-Yuste C, Lledo T, Martin-Villa J, Suarez-Trujillo F Mol Biol Rep. 2024; 52(1):6.

PMID: 39570459 DOI: 10.1007/s11033-024-10086-7.


The Immune Modulation Full Allele Is Associated with Gastric Adenocarcinoma Development.

Suarez-Trujillo F, Juarez I, Vaquero-Yuste C, Gutierrez-Calvo A, Lopez-Garcia A, Lasa I Int J Mol Sci. 2024; 25(19).

PMID: 39408976 PMC: 11476450. DOI: 10.3390/ijms251910645.


Complex Interactions between the Human Major Histocompatibility Complex (MHC) and Microbiota: Their Roles in Disease Pathogenesis and Immune System Regulation.

Arnaiz-Villena A, Juarez I, Vaquero-Yuste C, Lledo T, Martin-Villa J, Suarez-Trujillo F Biomedicines. 2024; 12(8).

PMID: 39200390 PMC: 11352054. DOI: 10.3390/biomedicines12081928.


Long-read single-cell sequencing reveals expressions of hypermutation clusters of isoforms in human liver cancer cells.

Liu S, Yu Y, Ren B, Ben-Yehezkel T, Obert C, Smith M Elife. 2024; 12.

PMID: 38206124 PMC: 10945587. DOI: 10.7554/eLife.87607.


Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a "Trojan Horse".

Karpov D, Sosnovtseva A, Pylina S, Bastrich A, Petrova D, Kovalev M Int J Mol Sci. 2023; 24(24).

PMID: 38139149 PMC: 10743607. DOI: 10.3390/ijms242417320.


References
1.
Klein J, Sato A . The HLA system. First of two parts. N Engl J Med. 2000; 343(10):702-9. DOI: 10.1056/NEJM200009073431006. View

2.
Hviid T . HLA-G in human reproduction: aspects of genetics, function and pregnancy complications. Hum Reprod Update. 2005; 12(3):209-32. DOI: 10.1093/humupd/dmi048. View

3.
Donadi E, Castelli E, Arnaiz-Villena A, Roger M, Rey D, Moreau P . Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci. 2010; 68(3):369-95. PMC: 3021195. DOI: 10.1007/s00018-010-0580-7. View

4.
Carosella E, Moreau P, LeMaoult J, Rouas-Freiss N . HLA-G: from biology to clinical benefits. Trends Immunol. 2008; 29(3):125-32. DOI: 10.1016/j.it.2007.11.005. View

5.
Carosella E, Favier B, Rouas-Freiss N, Moreau P, LeMaoult J . Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood. 2008; 111(10):4862-70. DOI: 10.1182/blood-2007-12-127662. View